Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shampoo regimen aims to soothe scalp after hair transplants

NCT ID NCT07641686

Disease control Sponsor: ChinaNorm Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special shampoo regimen can improve scalp health and reduce dandruff in 120 Chinese men who have had hair transplants. Some participants have mild-to-moderate seborrheic dermatitis (a common dandruff condition). The test group uses a special shampoo plus basic shampoo, while control groups use only basic shampoo. Researchers will measure scalp oil, moisture, and skin barrier function to see if the special shampoo helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
test shampoo plus basic shampoo
What this could lead to
If successful, this could point toward an improved scalp care routine that reduces dandruff and supports healing after hair transplants.
What could go wrong
This is an early-stage study with only 120 participants, so results may not apply to everyone. The intervention is just a shampoo, so any benefits are likely modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy Chinese male subjects aged between 18 and 55 years old; 2. Diagnosed with androgenetic alopecia, with alopecia grade from Grade II to Grade VI per Hamilton-Norwood classification; 3. Scheduled to receive hair transplantation; scalp condition is confirmed suitable for trial participation by dermatologist assessment after hair graft surgery; 4. With or without mild-to-moderate scalp seborrheic dermatitis (SD score ranging from 0 to 9); 5. No anti-dandruff shampoo used within the latest 14 days prior to enrollment; 6. No hair dyeing, perming or hair styling cosmetic treatments in the past 30 days; 7. Able to comply with all scheduled study visits; 8. Possess normal communication and comprehension capacity; 9. Agree to regular follow-up visits and complete related questionnaires on time; 10. Fully understand trial procedures, volunteer to join the study and provide written informed consent. Exclusion Criteria: 1. Suffering from severe scalp seborrheic dermatitis; 2. Received oral or topical antifungal drugs, glucocorticoids or other therapeutic medicines for seborrheic dermatitis within the preceding 30 days; 3. Complicated with other scalp diseases (such as psoriasis), or with obvious infection or unhealed wounds on the target treatment area; 4. Known hypersensitivity to ingredients including selenium disulfide, salicylic acid and related components; 5. History of autoimmune diseases or severe organic diseases involving heart, brain, lung, liver, kidney and other vital organs; 6. Past medical history of psychiatric or psychological disorders; 7. Refuse to sign the written informed consent form; 8. Currently enrolled in another interventional clinical trial; 9. Diagnosed with alopecia areata, pseudopelade, cicatricial alopecia or other scalp and hair disorders; 10. Have taken part in any other clinical trial within the prior 3 months; 11. Judged as inappropriate for trial participation based on investigator's clinical assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Androgenetic alopecia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

androgenetic alopecia seborrheic dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hair transplantation Scalp care Seborrheic dermatitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072, Shanghai,

    RECRUITING

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.